Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Regulatory Path Retatrutide is not yet approved for the treatment of obesity or type 2 diabetes
Retatrutide alone remains the evidence leader The strongest direct evidence is for retatrutide alone
the ratio between components is fixed and cannot be changed
This genetic insight identifies your unique peptide-pathway vulnerabilities and strengths across 150+ genetic insights, allowing your treatment plan to evolve based on your biology rather than guesswork
The body absorbs it gradually, keeping its effects steady until the next dose
US$ 29.51
US$ 26.01
US$ 24.06
US$ 27.61
